MDV Pharma
ActiveSummary
The computed 12-month bankruptcy probability of MDV Pharma is 1.9% (moderate). The 2024 annual accounts show equity of €266,703 and a net result of €94,429. Equity is growing by ~66.5% per year across the filed fiscal years. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2024
Axes · tick = 2023
Profitability50▼-23
Solvency42▲+2
Growth78=
Track record100
Bankruptcy probability, 12 months
1.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €12,000 at 30 days acceptable
Liquidity short (current ratio 0.24 against 0.19 in 2023; short-term debt: 42% and cash: 4% of total assets), and 83.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-06-2026, 43 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
43 d early
2024
17 d early
2023
14 d early
2022
97 d early
2021
38 d early
2020
31 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 30 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 23 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€266,703▲ 11.0%
2023 · €240,274
Total assets
€1.6m▲ 1.6%
2023 · €1.6m
Net result
€94,429▼ 44.9%
2023 · €171,489
Working capital
-€509,734▼ 1.7%
2023 · -€501,311
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€52,794-€54,240▲ 2.7%€10,063▼ 81.4%€30,057▲ 199%€11,093▼ 63.1%
Net result€41,817above the sector's middle half-€42,513above the sector's middle half▲ 1.7%-€45within the sector's middle half€171,489above the sector's middle half€94,429above the sector's middle half▼ 44.9%
Equity€44,317within the sector's middle half-€86,830within the sector's middle half▲ 95.9%€86,785within the sector's middle half▼ 0.1%€240,274above the sector's middle half▲ 177%€266,703above the sector's middle half▲ 11.0%
Total assets€79,669within the sector's middle half-€137,416within the sector's middle half▲ 72.5%€1.5mabove the sector's middle half▲ 1,003%€1.6mabove the sector's middle half▲ 3.1%€1.6mabove the sector's middle half▲ 1.6%
Debt€35,352-€50,587▲ 43.1%€1.4m▲ 2,726%€1.3m▼ 7.5%€1.3m▼ 0.1%
Working capital€37,366within the sector's middle half-€80,368within the sector's middle half▲ 115%-€564,353below the sector's middle half-€501,311below the sector's middle half▲ 11.2%-€509,734below the sector's middle half▼ 1.7%
Solvency55.6%within the sector's middle half-63.2%above the sector's middle half▲ 7.6pp5.7%within the sector's middle half▼ 57.5pp15.4%within the sector's middle half▲ 9.7pp16.8%within the sector's middle half▲ 1.4pp
Current ratio2.84above the sector's middle half-3.01above the sector's middle half▲ 0.170.15below the sector's middle half▼ 2.850.19below the sector's middle half▲ 0.040.24below the sector's middle half▲ 0.05
Return on assets (ROA)52.5%above the sector's middle half-30.9%above the sector's middle half▼ 21.6pp0.0%within the sector's middle half▼ 30.9pp11.0%within the sector's middle half▲ 11.0pp5.9%within the sector's middle half▼ 5.0pp
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 63% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.6m
Fixed assets
€1.4m ▼ 1.0%
Current assets
€156,951 ▲ 33.9%
Equity and liabilities €1.6m
Equity
€266,703 ▲ 11.0%
Debt
€1.3m ▼ 0.1%
Debt's share of the balance-sheet total falls from 84.6% to 83.2%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€19,079▼
2023 · €35,388
Cash flow
€102,415▼
2023 · €176,820
Debt to equity
4.95▼
2023 · 5.50
ROE
35.4%▼
2023 · 71.4%
Interest coverage
2.85▼
2023 · 4.89
Debt ≤ 1 year
€666,686▲
2023 · €618,504
Debt > 1 year
€646,392▼
2023 · €703,754
Income taxes
-€37▼
2023 · €1,332
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €2,550 | €4,995 | €5,119 | €5,330 | €7,986 | ▲ 49.8% |
| Other operating charges640/8 | - | €394 | €373 | €777 | €5,923 | ▲ 662% |
| Gross operating margin9900 | €55,759 | €59,628 | €15,555 | €36,165 | €25,002 | ▼ 30.9% |
| Operating profit (loss)9901 | €52,794 | €54,240 | €10,063 | €30,057 | €11,093 | ▼ 63.1% |
| Financial income75/76B | - | - | - | €150,000 | €90,000 | ▼ 40.0% |
| Recurring financial income75 | - | - | - | €150,000 | €90,000 | ▼ 40.0% |
| Financial charges65/66B | - | €104 | €8,108 | €7,236 | €6,701 | ▼ 7.4% |
| Recurring financial charges65 | €70 | €104 | €8,108 | €7,236 | €6,701 | ▼ 7.4% |
| Profit (loss) for the period before taxes9903 | €52,724 | €54,136 | €1,955 | €172,821 | €94,392 | ▼ 45.4% |
| Income taxes67/77 | €10,907 | €11,623 | €2,000 | €1,332 | -€37 | ▼ 103% |
| Profit (loss) for the period9904 | €41,817 | €42,513 | -€45 | €171,489 | €94,429 | ▼ 44.9% |
| Profit (loss) for the period to be appropriated9905 | €41,817 | €42,513 | -€45 | €171,489 | €94,429 | ▼ 44.9% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €79,669 | €137,416 | €1.5m | €1.6m | €1.6m | ▲ 1.6% |
| Formation expenses20 | €586 | €443 | €299 | €156 | €13 | ▼ 91.8% |
| Fixed assets21/28 | €21,395 | €16,543 | €1.4m | €1.4m | €1.4m | ▼ 1.0% |
| Tangible fixed assets22/27 | €21,395 | €16,543 | €12,927 | €44,545 | €29,679 | ▼ 33.4% |
| Furniture and vehicles24 | - | €16,543 | €12,927 | €44,545 | €29,679 | ▼ 33.4% |
| Financial fixed assets28 | - | - | €1.4m | €1.4m | €1.4m | = |
| Current assets29/58 | €57,688 | €120,430 | €102,411 | €117,193 | €156,951 | ▲ 33.9% |
| Amounts receivable within one year40/41 | €7,564 | €13,433 | €83,442 | €2,819 | €92,860 | ▲ 3,194% |
| Trade receivables40 | - | €13,433 | €18,000 | - | €38,736 | - |
| Other amounts receivable41 | - | - | €65,442 | €2,819 | €54,124 | ▲ 1,820% |
| Cash at bank and in hand54/58 | €50,124 | €106,998 | €18,969 | €114,374 | €64,092 | ▼ 44.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €79,669 | €137,416 | €1.5m | €1.6m | €1.6m | ▲ 1.6% |
| Equity10/15 | €44,317 | €86,830 | €86,785 | €240,274 | €266,703 | ▲ 11.0% |
| Contributions10/11 | - | €2,500 | €2,500 | €2,500 | €2,500 | = |
| Outside capital11 | - | €2,500 | €2,500 | €2,500 | €2,500 | = |
| Other1109/19 | - | €2,500 | €2,500 | €2,500 | €2,500 | = |
| Profit (loss) carried forward14 | €41,817 | €84,330 | €84,285 | €237,774 | €264,203 | ▲ 11.1% |
| Amounts payable17/49 | €35,352 | €50,587 | €1.4m | €1.3m | €1.3m | ▼ 0.1% |
| Amounts payable after more than one year17 | €15,030 | €10,524 | €762,727 | €703,754 | €646,392 | ▼ 8.2% |
| Financial debts170/4 | - | €10,524 | €762,727 | €703,754 | €646,392 | ▼ 8.2% |
| Amounts payable within one year42/48 | €20,322 | €40,063 | €666,764 | €618,504 | €666,686 | ▲ 7.8% |
| Current portion of amounts payable after more than one year42 | - | €4,176 | €58,469 | €58,973 | €57,362 | ▼ 2.7% |
| Trade debts44 | €891 | €3,315 | €642 | €3,090 | €3,448 | ▲ 11.6% |
| Suppliers440/4 | - | €3,315 | €642 | €3,090 | €3,448 | ▲ 11.6% |
| Advances received on contracts in progress46 | - | - | - | - | €2,500 | - |
| Taxes, remuneration and social security45 | - | €32,242 | €13,025 | €2,000 | €1,963 | ▼ 1.9% |
| Taxes450/3 | - | €30,942 | €13,025 | €2,000 | €1,963 | ▼ 1.9% |
| Remuneration and social security454/9 | - | €1,300 | - | - | - | - |
| Other amounts payable47/48 | - | €330 | €594,628 | €554,442 | €601,413 | ▲ 8.5% |
| Accrued charges and deferred income492/3 | - | - | - | - | €7,500 | - |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €41,817 | €42,513 | -€45 | €171,489 | €94,429 | ▼ 44.9% |
| + Depreciation and write-downs630 | €2,550 | €4,995 | €5,119 | €5,330 | €7,986 | ▲ 49.8% |
| Operating cash flow (approximation) | €44,367 | €47,508 | €5,074 | €176,820 | €102,415 | ▼ 42.1% |
| Investment in fixed assets (approximation) | - | -€143 | -€1.4m | -€36,949 | €6,881 | ▲ 119% |
| Change in cash | - | €56,874 | -€88,029 | €95,405 | -€50,282 | ▼ 153% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
18-06
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
14-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
17-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Back to profitnet €171,489
Net result €171,489 after one loss-making year.
31-12
Financial
Equity above €200,000Eq €240,274 ▲177%
Equity rises from €86,785 to €240,274.
25-04
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Weakest financial yearnet -€45
Net result drops to -€45, the lowest in the series; recovery starts the following year.
23-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Genappe · 1 establishment unit since 2020
Ground area
3,152 m²
Building footprint
719 m²
Parcel 25003D0001/00N006, Wallonia. Linked by address, not a title deed.
5
companies at this address
See who is registered here
1 establishment unit
MDV Pharma srl
since 20202.298.557.629
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 25003D0001/00N006 | Wallonia | 3,152 m² | 1 · 719 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 owner · 1 holdingChain of control
- PIMAC
- MDV Pharma
Highest known parent: PIMAC. The sources do not say who stands above it.
Owners 1
- PIMACparentSourceaccounts PIMAC 2024100%
Holdings 1
-
50%
According to the 2024 annual accounts of MDV Pharma and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Similar companies · same sector, comparable size
PHARMACIE SANDRINE DERKENNE
BE 0874.809.247
Verviers · Eq €266,459
APOTHEEK MOEREMANS
BE 0464.607.630
Ninove · Eq €266,450
PHARMACIE FRIPPIAT
BE 0630.878.102
Jemeppe-sur-Sambre · Eq €266,427
APOTHEEK DELHUVENNE
BE 0473.354.456
Aalter · Eq €267,396
APOTHEEK PALMANS
BE 0438.630.139
Lanaken · Eq €266,002
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,525 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded03-02-2020
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Contact
E-mail
pharmacien.independant.mdv@gmail.com
Phone
+32474972684
E-invoicing
Reachable via Peppol
Peppol ID
0208:0742814914
Registered
22-05-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.